Losing weight can pose a challenge, but how to avoid putting those pounds back on can be a real struggle. A major health problem for obese people is that diseases linked to obesity, such as type 2 diabetes and cardiovascular disease, put their lives at risk, even in young individuals. Although bariatric surgery—a surgical method to reduce or modify the gastrointestinal tract—was originally envisioned for the most severe cases of obesity, evidence suggests that the benefit of this procedure may not be limited to the staggering weight loss it causes. Endogenous factors released from the gut, and modified after surgery, may explain why bariatric surgery can be beneficial for obesity-related diseases and why operated individuals successfully maintain the weight loss. In 'Bedside to Bench,' Rachel Larder and Stephen O'Rahilly peruse a human study with dieters who regained weight despite a successful diet. Appetite-regulating hormones in the gut may be responsible for this relapse in the long term. In 'Bench to Bedside,' Keval Chandarana and Rachel Batterham examine how two different methods of bariatric surgery highlight the relevance of gut-derived hormones not only in inducing sustained weight loss but also in improving glucose homeostasis. These insights may open new avenues to bypass the surgery and obtain the same results with targeted drugs.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Kopelman, P.G. Nature 404, 635–643 (2000).
O'Rahilly, S. Nature 462, 307–314 (2009).
Buchwald, H. et al. J. Am. Med. Assoc. 292, 1724–1737 (2004).
Anderson, J.W. et al. Am. J. Clin. Nutr. 74, 579–584 (2001).
Sumithran, P. et al. N. Engl. J. Med. 365, 1597–1604 (2011).
Coll, A.P., Farooqi, I.S. & O'Rahilly, S. Cell 129, 251–262 (2007).
Scherer, T. & Buettner, C. Rev. Endocr. Metab. Disord. 12, 235–243 (2011).
Rosenbaum, M. et al. Am. J. Clin. Nutr. 88, 906–912 (2008).
Sjöström, L. et al. N. Engl. J. Med. 357, 741–752 (2007).
Karra, E., Yousseif, A. & Batterham, R.L. Trends Endocrinol. Metab. 21, 337–344 (2010).
Chandarana, K. et al. Diabetes 60, 810–818 (2011).
Meguid, M.M., Glade, M.J. & Middleton, F.A. Nutrition 24, 832–842 (2008).
Kindel, T.L. et al. J. Gastrointest. Surg. 13, 1762–1772 (2009).
Powell, A.G., Apovian, C.M. & Aronne, L.J. Clin. Pharmacol. Ther. 90, 40–51 (2011).
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Larder, R., O'Rahilly, S. Shedding pounds after going under the knife: Guts over glory—why diets fail. Nat Med 18, 666–667 (2012). https://doi.org/10.1038/nm.2747
This article is cited by
The Role of the Vagal Nucleus Tractus Solitarius in the Therapeutic Effects of Obesity Surgery and Other Interventional Therapies on Type 2 Diabetes
Obesity Surgery (2016)
The Effect of Gastrointestinal Surgery on Insulin Resistance and Insulin Secretion
Current Atherosclerosis Reports (2012)